26/04/2024  21:59:55 Var. +1.26 Volume Denaro- Lettera- Capitalizzazione di mercato Dividend Y. Rapporto P/E
229.06USD +0.55% 13,193
Fatturato: 3.03 mill.
-Quantità in denaro: - -Quantità in lettera: - 11.76 bill.USD - 24.71

Descrizione business

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Its employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
James C. Foster
Consiglio di amministrazione
Flavia Pease, William D. Barbo, Victoria L. Creamer, Birgit Girshick, Joseph W. LaPlume, Shannon M. Parisotto, Brian Bathgate, Ph.D., Matthew L. Daniel, Kerstin Dolph, Colin S. Dunn, Ph.D., Kristen M. Eisenhauer, Professor Julie Frearson, Ph.D., Wilbert Frieling, D.V.M., E.R.T., John C. Ho, M.D., Foster T. Jordan, Michael G. Knell, Mark Mintz, Gina M. Mullane, Barbara J. Patterson
Consiglio di sorveglianza
James C. Foster, Nancy C. Andrews M.D., Ph.D., Robert J. Bertolini, Deborah T. Kochevar, D.V.M., Ph.D., D.A.C.V.C.P., George Llado, Martin Mackay, Ph.D., George E. Massaro, C. Richard Reese, Craig B. Thompson, M.D., Richard F. Wallman, Virginia M. (Gina) Wilson
 

Dati aziendali

Name: Charles River Laboratories International, Inc.
Indirizzo: 251 Ballardvale Street,Wilmington, Massachusetts 01887, USA
Telefono: +1-781-222-6000
Fax: -
E-mail: -
Internet: www.criver.com
Industria: Biotechnology
Settore: Biotechnology
Sub settore: Biotechnology
Fine dell'anno finanziario: 31/12
Flottante libero: 88.30%
Data dell'IPO: 23/06/2000

Rapporti con gli investitori

Name: -
IR telefono: +1-781-222-6190
IR Fax: -
IR e-mail: askcharlesriver@crl.com